Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: A pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens-Reference-Cited by-同舟云学术

Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: A pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens

Published:2007-12 Issue:1 Volume:258 Page:45-54
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kai Keita,Kitajima Yoshihiko,Hiraki Masatsugu,Satoh Seiji,Tanaka Masayuki,Nakafusa Yuji,Tokunaga Osamu,Miyazaki Kohji

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies;Longley;Nat. Rev. Cancer,2003

2. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5,0-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes;Peters;Cancer Res.,1986

3. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa;Peters;Cancer,1991

4. Genetic factors influencing pyrimidine-antagonist chemotherapy;Maring;Pharmacogenomics J.,2005

5. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile;Heggie;Cancer Res.,1987

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between the DPD and TS mRNA Expression and the Response to S-1-Based Chemotherapy and Prognosis in Patients with Advanced Gastric Cancer;Cell Biochemistry and Biophysics;2014-11-12

2. Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy;Oncology Reports;2013-12-05

3. DPYD,TYMS,TYMP,TK1, andTK2Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy;BioMed Research International;2013

4. S-1 and the treatment of gastric cancer with peritoneal dissemination;Experimental and Therapeutic Medicine;2011

5. Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma;International Journal of Oncology;2010-09-01